Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2005
10/12/2005CN1680557A Penicillium marneffei CRG5 gene, its coding protein and use
10/12/2005CN1680555A Penicillium marneffei 60S ribosomal protein L33-B, its coding sequence and use
10/12/2005CN1680554A Penicillium marneffei thymus resistant glubolin, its coding sequence and use
10/12/2005CN1680427A Water soluble piduomode composite salt and its preparation
10/12/2005CN1680425A 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcaboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1, 4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflamatory agent
10/12/2005CN1680423A Compounds useful in the manufacture of an anti-inflammatory androstane derivative
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1680371A Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
10/12/2005CN1680367A Substituted 2-(2, 6-dioxopiperidin-3-yp)-phthalimides and 1-oxoisoindolines and method for reducing TNF alpha levels
10/12/2005CN1680353A Rice bean flavone extracts and their use
10/12/2005CN1680339A Benzimidazole derivative
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680333A Anti-virus pyrazole derivatives
10/12/2005CN1680324A Dihydropyridine soft drugs, and related compositions and methods
10/12/2005CN1680314A 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/12/2005CN1680284A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
10/12/2005CN1680259A Aspirin-triggered lipid mediators
10/12/2005CN1679966A Nanometer grainy and mucosal immunity of antiatherosclerosis nucleic vaccine
10/12/2005CN1679938A Pharmaceutical compositions
10/12/2005CN1679937A Compositions and methods for treating or preventing inflammatory diseases
10/12/2005CN1679935A Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist
10/12/2005CN1679932A Ordered molecular presentation of antigens, method of preparation and use
10/12/2005CN1679923A Oral enteric-coated microsphere of Thymosin and preparation thereof
10/12/2005CN1679919A Intracellular isoform of the interleukin-1 receptor antagonist
10/12/2005CN1679917A Oil-free pharmaceutical compositions containing cyclosporin A
10/12/2005CN1679916A Pharmaceutical compositions
10/12/2005CN1679915A Peptide antagonists of zonulin and methods for use of the same
10/12/2005CN1679862A Snuffles tablets and prescription thereof
10/12/2005CN1679612A Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity
10/12/2005CN1679567A Granules of clarityne and their production
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1679552A Preferential inhibition of release of pro-inflammatory cytokines
10/12/2005CN1679549A Use of FK506 nano powder in preparation of medicine for immuno-concerned diseases caused by corneal transplantation
10/12/2005CN1679527A Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same
10/12/2005CN1222612C Method of extensive culture of antigen-specific cytotoxic T cells
10/12/2005CN1222539C Human receptor proteins, related reagents and methods
10/12/2005CN1222529C Water soluble rapamycin esters
10/12/2005CN1222527C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
10/12/2005CN1222523C 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
10/12/2005CN1222520C Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
10/12/2005CN1222374C Extrusion die
10/12/2005CN1222286C Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953847 Fas antigen derivative
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953809 Monocyte chemoattractant protein-1 inhibitor compounds
10/11/2005US6953804 alkenyl ether functionality at 1-position; immunomodulators that induce cytokine biosynthesis; 1-[2-(2-Propynyloxy)ethyl]-1H-imidazo[4,5-c]quinolin-4-amine;
10/11/2005US6953798 compounds are able to inhibit binding of alpha 4 integrins to their ligands and are of use in prophylaxis and treatment of immune or inflammatory disorders
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/11/2005US6953795 N-[5-[[3[-(morpholin-4-yl)carbonyl]phenyl]thio]thiazol-2-yl]-4-(N,N-dimethylamino)benzamide; may be combined with antiinflammatory, antiarthritic, antiproliferative, anticancer, anti-cytotoxic or antiallergenic agents
10/11/2005US6953793 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection
10/11/2005US6953776 Ophthalmic formulations
10/11/2005US6953591 Administering to a mammal non-toxic effective T-cell function-mediated disorder-treating amount of phosphatidyl serine (PS) carrying bodies wherein progression of T-cell function-mediated disorder is inhibited
10/11/2005US6953581 Porcine circovirus and parvovirus vaccine
10/11/2005US6953578 Administering a prostaglandin-2 synthase inhibitor selected from indomethacin, animoguanadine or N-(2-(cyclohexyloxy)-4-nitrophenyl)methanesulfonamide for preventing or reducing severity of autoimmune disease
10/11/2005CA2087272C Cd53 cell surface antigen and use thereof
10/06/2005WO2005093064A1 Novel galectin 9 modification protein and use thereof
10/06/2005WO2005092893A1 9-substituted 8-oxoadenine compound
10/06/2005WO2005092892A1 8-oxoadenine compound
10/06/2005WO2005092357A1 Antiallergic agent and antiinflammatory agent
10/06/2005WO2005092322A1 Natural compound causing rar activation
10/06/2005WO2005092320A1 Cytoprotective composition
10/06/2005US20050223430 Gntiii expression in plants
10/06/2005US20050223416 C1 inhibitor produced in the milk of transgenic mammals
10/06/2005US20050222418 Novel tyloindicines and related processes, pharmaceutical compositions and methods
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222386 Biomolecule transduction motif sim-2-btm and the use thereof
10/06/2005US20050222253 Anti-cancer nitro- and thia-fatty acids
10/06/2005US20050222226 N-[3-(2-Aminoethyl)-4-(4-bromophenyl)thiazol-2(3H)-ylidene]aniline; antiinflammatory agents, antiallergens; inhibit infiltration of leukocytes such as eosinophils and lymphocytes; autoimmune diseases, asthma
10/06/2005US20050222221 Cell differentiation, regeneration of pancreas epithelial cells to insulin producing beta cells; administering a dipeptidyl-peptidase activators
10/06/2005US20050222216 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222189 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
10/06/2005US20050222160 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
10/06/2005US20050222153 Tyrosine kinase enzyme inhibitors as growth factor receptors and useful as antiproliferation agents
10/06/2005US20050222152 Enzyme inhibitors for disease treatment with Cathepsin s
10/06/2005US20050222147 Process for the preparation of morpholine derivatives and intermediates therefore
10/06/2005US20050222104 e.g. 3 beta -Formyloxy-21-acetyloxy-5-pregnen-20-one; modulate immunology response; disease associated to an excess of glucocorticoids; Cushing's syndrome, iatrogenic hypercortisolism or depression
10/06/2005US20050222097 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
10/06/2005US20050222065 Vascular therapeutics
10/06/2005US20050222062 Decoy for treating and/or preventing th2 cytokine-associated allergic disease, gata3 mutant protein and medicinal compositions containing the same
10/06/2005US20050222061 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/06/2005US20050222060 Compositions and methods to initiate or enhance antibody and major-histocompatibility class I or class II-restricted t cell responses by using immunomodulatory, non-coding rna motifs
10/06/2005US20050222025 Method of inhibiting fibrosis with a somatostatin agonist
10/06/2005US20050222019 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
10/06/2005US20050222017 Apoptosis promoter and inhibitor interacting with cgi-94, and method of screening the same
10/06/2005US20050221368 Methods for identifying RNA binding compounds
10/06/2005US20050221347 Inhibitors of binding between proteins and macromolecular ligands
10/06/2005US20050221344 Interferon-Like molecules and uses thereof
10/06/2005US20050221299 Peptide from the glycoprotein B from human herpesvirus 7 for use in a serological ELISA test
10/06/2005US20050221287 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation
10/06/2005US20050220906 Pharmaceutical composition for treating rheumatism and the preparation thereof
10/06/2005US20050220888 Controlled release compositions and methods for using same
10/06/2005US20050220858 Codelivery to a cell of nucleic acid and assistor protein (antigen) where the nucleic acid encodes an antigenic protein or which shares an epitope(s) with the assistor protein; the nucleic acid is entrapped in liposome intravesicular space; assistor protein is on the liposome surface; synergistic
10/06/2005US20050220819 Novel binding epitopes for helicobacter pylori and use thereof
10/06/2005US20050220812 Screening process
10/06/2005US20050220804 Increasing an immune response in an animal, comprising administering a compound (such as a carbohydrate, an antibiotic, a sugar, a protein, or an antibody) that binds a C-type lectin (but not the DEC-205 receptor) on the surface of a dendritic cell
1 ... 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 ... 1172